CD91.DE vs. FKRCX

Last updated Jun 26, 2026

CD91.DE (Amundi NYSE Arca Gold Bugs UCITS ETF Dist) and FKRCX (Franklin Gold and Precious Metals Fund) are both Gold funds. Over the past 10 years, CD91.DE returned 10.60%/yr vs 12.74%/yr for FKRCX. A 0.68 correlation means they provide meaningful diversification when combined. CD91.DE charges 0.65%/yr vs 0.88%/yr for FKRCX.

Performance

CD91.DE vs. FKRCX - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) and Franklin Gold and Precious Metals Fund (FKRCX). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CD91.DE is traded in EUR, while FKRCX is traded in USD. To make them comparable, the FKRCX values have been converted to EUR using the latest available exchange rates.

Returns By Period

The year-to-date returns for both stocks are quite close, with CD91.DE having a -8.09% return and FKRCX slightly lower at -8.15%. Over the past 10 years, CD91.DE has underperformed FKRCX with an annualized return of 10.60%, while FKRCX has yielded a comparatively higher 12.74% annualized return.

CD91.DE

• 1D: 1.23%
• 1M: -10.88%
• YTD: -8.09%
• 6M: -10.48%
• 1Y: 58.41%
• 3Y*: 38.73%
• 5Y*: 20.74%
• 10Y*: 10.60%

FKRCX

• 1D: -4.42%
• 1M: -15.02%
• YTD: -8.15%
• 6M: -11.08%
• 1Y: 65.87%
• 3Y*: 45.38%
• 5Y*: 20.51%
• 10Y*: 12.74%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CD91.DE vs. FKRCX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CD91.DE Amundi NYSE Arca Gold Bugs UCITS ETF Dist	-8.09%	132.46%	20.72%	2.57%	-1.60%	-7.98%	15.46%	49.85%	-12.28%	-11.15%
FKRCX Franklin Gold and Precious Metals Fund	-8.15%	161.39%	25.41%	-1.03%	-18.72%	3.15%	32.41%	54.90%	-14.27%	-12.39%

Correlation

The correlation between CD91.DE and FKRCX is 0.74, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.74
Correlation (3Y) Calculated over the trailing 3-year period	0.73
Correlation (5Y) Calculated over the trailing 5-year period	0.74
Correlation (10Y) Calculated over the trailing 10-year period	0.70
Correlation (All Time) Calculated using the full available price history since May 11, 2010	0.68

The correlation between CD91.DE and FKRCX has been stable across timeframes, ranging from 0.68 to 0.74 - a consistent structural relationship.

Return for Risk

CD91.DE vs. FKRCX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CD91.DE

CD91.DE Risk / Return Rank: 37
CD91.DE Sharpe Ratio Rank: 40
CD91.DE Sortino Ratio Rank: 37
CD91.DE Omega Ratio Rank: 37
CD91.DE Calmar Ratio Rank: 38
CD91.DE Martin Ratio Rank: 33

FKRCX

FKRCX Risk / Return Rank: 28
FKRCX Sharpe Ratio Rank: 32
FKRCX Sortino Ratio Rank: 26
FKRCX Omega Ratio Rank: 31
FKRCX Calmar Ratio Rank: 30
FKRCX Martin Ratio Rank: 23

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CD91.DE vs. FKRCX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) and Franklin Gold and Precious Metals Fund (FKRCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CD91.DE	FKRCX	Difference
Sharpe ratio: Return per unit of total volatility	1.29	1.52	-0.22
Sortino ratio: Return per unit of downside risk	1.77	1.91	-0.14
Omega ratio: Gain probability vs. loss probability	1.22	1.27	-0.04
Calmar ratio: Return relative to maximum drawdown	1.75	1.90	-0.15
Martin ratio: Return relative to average drawdown	4.51	5.13	-0.62

CD91.DE vs. FKRCX - Sharpe Ratio Comparison

The current CD91.DE Sharpe Ratio is 1.29, which is comparable to the FKRCX Sharpe Ratio of 1.52. The chart below compares the historical Sharpe Ratios of CD91.DE and FKRCX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CD91.DE vs. FKRCX - Drawdown Comparison

The maximum CD91.DE drawdown since its inception was -83.13%, which is greater than FKRCX's maximum drawdown of -74.19%. Use the drawdown chart below to compare losses from any high point for CD91.DE and FKRCX.

Drawdown Indicators

	CD91.DE	FKRCX	Difference
Max Drawdown Largest peak-to-trough decline	-83.13%	-74.19%	-8.94%
Max Drawdown (1Y) Largest decline over 1 year	-33.29%	-33.90%	+0.61%
Max Drawdown (3Y) Largest decline over 3 years	-33.29%	-33.90%	+0.61%
Max Drawdown (5Y) Largest decline over 5 years	-39.55%	-43.19%	+3.64%
Max Drawdown (10Y) Largest decline over 10 years	-55.41%	-51.41%	-4.00%
Current Drawdown Current decline from peak	-31.05%	-32.06%	+1.01%
Average Drawdown Average peak-to-trough decline	-53.47%	-37.71%	-15.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.91%	12.51%	+0.40%

Volatility

CD91.DE vs. FKRCX - Volatility Comparison

Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) and Franklin Gold and Precious Metals Fund (FKRCX) have volatilities of 17.14% and 16.81%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CD91.DE	FKRCX	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.14%	16.81%	+0.33%
Volatility (6M) Calculated over the trailing 6-month period	36.98%	36.22%	+0.76%
Volatility (1Y) Calculated over the trailing 1-year period	44.98%	42.46%	+2.52%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	34.94%	31.62%	+3.32%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	34.55%	30.91%	+3.64%

CD91.DE vs. FKRCX - Expense Ratio Comparison

CD91.DE has a 0.65% expense ratio, which is lower than FKRCX's 0.88% expense ratio.

Dividends

CD91.DE vs. FKRCX - Dividend Comparison

CD91.DE's dividend yield for the trailing twelve months is around 0.17%, less than FKRCX's 12.10% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
CD91.DE Amundi NYSE Arca Gold Bugs UCITS ETF Dist	0.17%	0.16%	0.33%	2.50%	1.04%	0.54%	0.17%	0.33%	0.00%	0.69%	0.00%
FKRCX Franklin Gold and Precious Metals Fund	12.10%	10.75%	13.44%	3.12%	0.00%	9.37%	10.55%	0.00%	0.00%	0.37%	8.73%

Frequently Asked Questions

Can I hold both CD91.DE and FKRCX in my portfolio?

CD91.DE and FKRCX have a correlation of 0.74, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.